PT Hetzer Medical Indonesia Tbk (ISX:MEDS) ROE %: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:MEDS PT Hetzer Medical Indonesia Tbk ISX:MEDS
21 GF Score
Price Rp82.00
! 2 Warning Signs
View Full Analysis

What is PT Hetzer Medical Indonesia Tbk ROE %?

PT Hetzer Medical Indonesia Tbk ISX:MEDS +1.23% 21 ROE % is 0.00% as of . 20. GuruFocus rates ISX:MEDS with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 799 Medical Devices & Instruments companies, PT Hetzer Medical Indonesia Tbk ranks worse than 125156.32% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. PT Hetzer Medical Indonesia Tbk's annualized net income for the quarter that ended in . 20 was Rp Mil. PT Hetzer Medical Indonesia Tbk's average Total Stockholders Equity over the quarter that ended in . 20 was Rp Mil. Therefore, PT Hetzer Medical Indonesia Tbk's annualized ROE % for the quarter that ended in . 20 was %.

The historical rank and industry rank for PT Hetzer Medical Indonesia Tbk's ROE % or its related term are showing as below:

ISX:MEDS's ROE % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.54
* Ranked among companies with meaningful ROE % only.

PT Hetzer Medical Indonesia Tbk  (ISX:MEDS) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: . 20 )
=Net Income/Total Stockholders Equity
=/
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=( / )*( / )*( / )
=Net Margin %*Asset Turnover*Equity Multiplier
= %**
=ROA %*Equity Multiplier
= %*
= %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: . 20 )
=Net Income/Total Stockholders Equity
=/
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= ( / ) * ( / ) * ( / ) * ( / ) * ( / )
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= * * % * *
= %

Note: The net income data used here is one times the annual (. 20) net income data. The Revenue data used here is one times the annual (. 20) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


PT Hetzer Medical Indonesia Tbk ROE % Related Terms


PT Hetzer Medical Indonesia Tbk ROE % Historical Data

* Premium members only.

The historical data trend for PT Hetzer Medical Indonesia Tbk's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Hetzer Medical Indonesia Tbk ROE % Chart

PT Hetzer Medical Indonesia Tbk Annual Data
Trend
ROE %

PT Hetzer Medical Indonesia Tbk Semi-Annual Data
ROE %

ISX:MEDS vs ISRG, BDX, MDLN: ROE % Comparison

For the Medical Instruments & Supplies subindustry, PT Hetzer Medical Indonesia Tbk's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Hetzer Medical Indonesia Tbk ROE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT Hetzer Medical Indonesia Tbk's ROE % distribution charts can be found below:

* The bar in red indicates where PT Hetzer Medical Indonesia Tbk's ROE % falls into.


ISX:MEDS
21GF Score
PT Hetzer Medical Indonesia Tbk ISX:MEDS
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Hetzer Medical Indonesia Tbk ROE % Calculation

PT Hetzer Medical Indonesia Tbk's annualized ROE % for the fiscal year that ended in . 20 is calculated as

ROE %=Net Income (A: . 20 )/( (Total Stockholders Equity (A: . 20 )+Total Stockholders Equity (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

PT Hetzer Medical Indonesia Tbk's annualized ROE % for the quarter that ended in . 20 is calculated as

ROE %=Net Income (Q: . 20 )/( (Total Stockholders Equity (Q: . 20 )+Total Stockholders Equity (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (. 20) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 0.00% mean?
PT Hetzer Medical Indonesia Tbk (ISX:MEDS) has a ROE % of 0.00% as of . 20. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on PT Hetzer Medical Indonesia Tbk and its competitors. According to the industry distribution chart, PT Hetzer Medical Indonesia Tbk ranks #999999 out of 799 companies in the Medical Devices & Instruments industry.
Is PT Hetzer Medical Indonesia Tbk's ROE % too high?
PT Hetzer Medical Indonesia Tbk's current ROE % is 0.00%. Based on the distribution chart, PT Hetzer Medical Indonesia Tbk ranks #999999 out of 799 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PT Hetzer Medical Indonesia Tbk has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does PT Hetzer Medical Indonesia Tbk's ROE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PT Hetzer Medical Indonesia Tbk ranks #999999 out of 799 companies for ROE %. This places PT Hetzer Medical Indonesia Tbk in the lower half of its industry. The industry median ROE % is 2.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.54, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on PT Hetzer Medical Indonesia Tbk and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Hetzer Medical Indonesia Tbk's current ROE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Hetzer Medical Indonesia Tbk stock overvalued right now?
PT Hetzer Medical Indonesia Tbk (ISX:MEDS) has a current ROE % of 0.00%. The current ROE % is 0.00%. PT Hetzer Medical Indonesia Tbk's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For PT Hetzer Medical Indonesia Tbk (ISX:MEDS), the current ROE % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Hetzer Medical Indonesia Tbk Business Description

Address Jl. Mahar Martanegara No. 106, Kel. Cigugur Tengah, Kec. Cimahi Tengah, Provinsi Jawa Barat, Kota Cimahi, IDN, 40522
PT Hetzer Medical Indonesia Tbk is a pioneer in Indonesia which produces 4 Dimensional Ear Loop type health masks with the trademark Evo Plusmed.
21GF Score

Get the complete analysis for ISX:MEDS

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp82.00
Price